HNRNPF Protein
Overview
HNRNPF (Heterogeneous Nuclear Ribonucleoprotein F) is a RNA-binding protein encoded by the HNRNPF gene located on chromosome 10q11.23. It belongs to the heterogeneous nuclear ribonucleoprotein (hnRNP) family, a group of proteins that associate with nascent pre-mRNA transcripts and regulate multiple aspects of RNA metabolism. HNRNPF exists as part of the broader hnRNP superfamily alongside related proteins such as HNRNPA1, HNRNPA2B1, and HNRNPD, each with specialized but overlapping functions in RNA processing. The protein was initially characterized for its ability to bind specifically to GU-rich and U-rich sequences in RNA molecules, making it a sequence-specific regulator of gene expression at the post-transcriptional level.
Function/Biology
HNRNPF functions primarily as a modular RNA-binding protein with two tandem RNA Recognition Motifs (RRMs) located in its N-terminal region, which confer high-affinity binding to target RNA sequences. These RRMs enable the protein to recognize and bind preferentially to GU-rich and AU-rich sequences within the 3' untranslated regions (3' UTRs) and intronic regions of target mRNAs. Beyond its RNA-binding capacity, HNRNPF contains an auxiliary domain rich in glycine residues that facilitates protein-protein interactions with other components of the spliceosome and RNA-processing machinery.
...HNRNPF Protein
Overview
HNRNPF (Heterogeneous Nuclear Ribonucleoprotein F) is a RNA-binding protein encoded by the HNRNPF gene located on chromosome 10q11.23. It belongs to the heterogeneous nuclear ribonucleoprotein (hnRNP) family, a group of proteins that associate with nascent pre-mRNA transcripts and regulate multiple aspects of RNA metabolism. HNRNPF exists as part of the broader hnRNP superfamily alongside related proteins such as HNRNPA1, HNRNPA2B1, and HNRNPD, each with specialized but overlapping functions in RNA processing. The protein was initially characterized for its ability to bind specifically to GU-rich and U-rich sequences in RNA molecules, making it a sequence-specific regulator of gene expression at the post-transcriptional level.
Function/Biology
HNRNPF functions primarily as a modular RNA-binding protein with two tandem RNA Recognition Motifs (RRMs) located in its N-terminal region, which confer high-affinity binding to target RNA sequences. These RRMs enable the protein to recognize and bind preferentially to GU-rich and AU-rich sequences within the 3' untranslated regions (3' UTRs) and intronic regions of target mRNAs. Beyond its RNA-binding capacity, HNRNPF contains an auxiliary domain rich in glycine residues that facilitates protein-protein interactions with other components of the spliceosome and RNA-processing machinery.
The primary biological functions of HNRNPF include pre-mRNA splicing, mRNA export, mRNA localization, and mRNA stability regulation. In the context of alternative splicing, HNRNPF acts as a splicing regulator by promoting or inhibiting the inclusion of specific exons depending on its binding location relative to splice sites. The protein also participates in mRNA export from the nucleus by interacting with nuclear export factors and helping to remodel ribonucleoprotein complexes into export-competent conformations. Additionally, HNRNPF influences mRNA localization within the cytoplasm and regulates the half-life of certain transcripts by modulating the accessibility of regulatory elements to decay machinery.
Role in Neurodegeneration
HNRNPF has emerged as a significant factor in neurodegenerative disease pathogenesis through multiple mechanistic pathways. The protein is implicated in the dysregulation of tau protein splicing and expression, a hallmark feature of Alzheimer's disease and other tauopathies. Altered HNRNPF activity can shift the balance toward production of pro-pathogenic tau isoforms lacking exon 10, which exhibit enhanced aggregation propensity and toxicity in neurons.
In amyotrophic lateral sclerosis (ALS), HNRNPF dysfunction contributes to the dysregulation of survival motor neuron (SMN) splicing and the impaired expression of neuroprotective factors. The protein's RNA-binding capacity can be compromised by sequestration into cytoplasmic stress granules and by interactions with pathological protein aggregates, including TDP-43 and FUS inclusions that characterize ALS pathology. Furthermore, mutations or aberrant modifications of HNRNPF have been associated with impaired mRNA export and accumulation of cryptic introns in the nucleus, triggering innate immune responses that contribute to neuroinflammation.
Molecular Mechanisms
The neurodegenerative mechanisms involving HNRNPF operate through several interconnected pathways. Loss of HNRNPF function or sequestration leads to aberrant splicing patterns of neuronal genes encoding proteins essential for synaptic function, axonal transport, and proteostasis. The dysregulation of GU-rich element-containing mRNAs encoding neurotrophic factors, synaptic scaffolding proteins, and RNA-binding proteins themselves creates a cascading failure of cellular homeostasis.
Phosphorylation of HNRNPF by stress-responsive kinases, including GSK3β and JNK, modulates its RNA-binding affinity and localization. Under pathological conditions, hyperphosphorylated HNRNPF becomes sequestered in neuronal inclusions and stress granules, reducing its availability for normal RNA processing functions. This sequestration mechanism parallels that observed with other hnRNPs in neurodegenerative diseases, suggesting a common vulnerability of the RNA-binding protein machinery to proteotoxic stress.
Clinical/Research Significance
HNRNPF represents both a therapeutic target and a biomarker candidate for neurodegenerative diseases. Understanding HNRNPF dysfunction could enable development of small-molecule modulators or antisense oligonucleotides to restore proper splicing patterns or increase protein expression. Research has demonstrated that restoring HNRNPF levels or activity rescues tau-associated phenotypes in cellular and animal models of tauopathy. Additionally, circulating HNRNPF protein levels and phosphorylation status may serve as accessible biomarkers for disease progression and response to therapeutic interventions.
- HNRNPA1 - Functionally relate